February 1, 2010
By:Elaine Zablocki
Poor adherence is the most common cause of treatment failure. Months of treatment and observation produces improvement
 |
January 1, 2010
By:Mari Edlin
Transparent models are fee-based, but do plan sponsors gain anything from such arrangements?
|
June 12, 2009
By:Tracey Walker
The disparity in coverage between oral and IV chemotherapy medication is a critical issue for patients and is being debated at the national and federal levels.
|
June 12, 2009
By:Tracey Walker
Wal-Mart pharmacy programs has industry rethinking benefit approaches.
|
May 1, 2009
By:Mari Edlin
Reduced copays encourage patient compliance with drug regimens, but broader tagets are needed
|
April 10, 2009
By:Tracey Walker
Prescription drug trends show that the underinsured may be voluntarily opting out of compliance due to affordability issues. Lower copayments may be key to curbing this.
|
April 1, 2009
By:Mari Edlin
Specialty drugs bring about the need for a sales force with more clinical knowledge
|
March 1, 2009
By:Mari Edlin
One of the main criticisms of consumer-directed health plans questions whether members avoid needed medications to save money
|
January 1, 2009
By:Jill Wechsler
Cancer patient advocates are concerned that management strategies are reducing access to treatment options.
|
| 
